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ABSTRAK 
 Kanser serviks merupakan tempat keempat penyebab utama kematian akibat kanser 
dalam kalangan wanita di seluruh dunia. Kadar insiden dan kematian adalah lebih tinggi di 
negara membangun termasuk Malaysia. Walaupun taraf hidup pesakit telah meningkat oleh 
kemajuan pesat kemoterapi neoadjuvan, dan pembedahan atau kedua-duanya, tetapi masih 
mengakibatkan kadar kematian yang ketara. Selain itu, kebanyakan rawatan semasa tidak 
menunjukkan peningkatan dan mengakibatkan kesan sampingan kepada pesakit. Pada masa 
ini, pendekatan kepada strategi kemo-pencegahan menggunakan bahan semulajadi menjadi 
tumpuan dalam kalangan penyelidik. Kajian ini bertujuan untuk mengkaji potensi ekstrak 
daun Goniothalamus umbrosus (Kenerak) terhadap kesan kemo-pencegahan ke atas sel 
kanser serviks, HeLa. Kaedah MTS dan AlamarBlue menunjukkan dos IC50 bagi ekstrak 
daun G. umbrosus adalah 45.31 µg/ml dan 48.44 µg/ml masing-masing. Perubahan morfologi 
menunjukkan proses apoptosis boleh diperhatikan bagi rawatan dengan ekstrak daun G. 
umbrosus seperti pengecutan sel, pembulatan sel, penvakuolan dan pemanjangan sel. Analisis 
pembiakan sel yang dijalankan selama 72 jam telah menunjukkan bahawa ekstak daun G. 
umbrosus mempunyai kesan anti-proliferatif. Secara keseluruhan, data yang terkumpul dari 
kajian ini membuka ruang baru terhadap ekstrak daun G. umbrosus sebagai agen kemo-
pencegahan terhadap kanser serviks.  
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ABSTRACT 
 Cervical cancer is the fourth leading cause of cancer death in female worldwide. The 
rate of incidence and mortality is higher in developing countries including Malaysia. 
Although the survival of the patients had increased due to the rapid advancement of 
neoadjuvant chemotherapy and surgery or both, but there still results in substantial morbidity. 
Moreover, most of the cases for current treatments do not show improvement and results side 
effects to the patients. Currently, chemoprevention approach using natural products is one of 
great interact among researchers. This study evaluated the potentially of the Goniothalamus 
umbrosus (Kenerak) leaves extracts in exhibiting chemopreventative effects on cervical 
cancer cell (HeLa cells). The IC50 of the extracts were determined with MTS and AlamarBlue 
assay lies in 45.31 µg/ml and 48.44 µg/ml respectively. Morphological changes displaying 
apoptosis can be observed upon treatment with G. umbrosus leaves extracts, including cell 
shrinkage, rounding of cells, vacuolization and cell elongation. The 3 days cell proliferation 
assay indicated that G. umbrosus leaves extracts has an anti-proliferative effects. Overall, the 
data collected provide new insight of using G. umbrosus leaves extracts which can be used as 
chemopreventive agent on cervical cancer. 
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CHAPTER 1 
INTRODUCTION 
Cancer disease was reported over 6 million cases per year and became the 
second cause of death after the cardiovascular disease (Srivastava et al., 2005). Cervical 
cancer is the third most frequent diagnosed cancer and the fourth most frequent cause of 
cancer among female, the report in the year 2008 indicated 9% (529800) of the total 
new cancer cases and 8% of the total cancer deaths among female (Jemal et al., 2011).  
According to American Cancer Society, a new analysis estimated that within six 
minutes, a gynaecological cancer is diagnosed with the majority of cervical cancer 
(American Cancer Society, 2010). A study in Malaysia, Omar and Tamin (2011), 
reported that the cervical cancer is the third most common cancer among female, with 
the total of 847 issue cases diagnosed. The data indicated that the rate of incidence and 
mortality is higher in developing countries including Malaysia. 
The uses of natural product especially from plant derived products as alternative 
therapies is growing an interest among researchers (Goldfrank et al., 1982; Vulto and 
Smet, 1988; Mentz and Schenkel, 1989). Thus, in modern era, the research on medicinal 
plants for development of new drugs are needed for the needs of the pharmaceutical 
market (Elisabetsky, 1987a; Calixto, 1996) 
In December 1967, the record on plant dependent anti-cancer drug from 
published and unpublished works were first published by Hartwell with monumental 
information of 3000 species of plants with anticancer property (Graham et al., 2000). 
The National Cancer Institute ratified 114,000 anticancer plant extracts from 35,000 
plant species from 20 countries (Shoeb et al., 2005). 
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Goniothalamus is the second largest genus of Annonaceae and in Asia, the 
Goniothalamus has been widely used for traditional practices in Asia (Nasir et al., 2004) 
Goniothalamus umbrosus, or well known as „kenerak‟, is possibly one of the 
interesting medicinal plants of the East coast of the Peninsular Malaysia. It is  grown by 
generations of traditional practitioners mostly for healthcare. Based on the previous 
study, the Goniothalamus has a very special compound that can only be found within 
the family of Annonaceae, known as styrylpyrone goniothalamin. One of its bioactive 
fraction is  styryl-lactones , that is predominantly restricted to the genus Goniothalamus. 
Goniothalamin is the first styryllactone (Nasir et al., 2004) 
The bioactive styryl-lactone has been reported by the previous study that it can 
show medicinal properties against many diseases and anti-cancer that will cause 
apoptosis of various human tumours and animal cell lines  (Nasir et al., 2004).  
The present investigation was carried out to determine  the anticancer potential 
of medicinal plant extracts of G. umbrosus. Understanding of the anti-cancer activity of  
extracts may provides useful information for developing anti-cancer treatment in future. 
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1.1 OBJECTIVE 
Main Objectives 
 To determine the effects of G. umbrosus extracts on HeLa cell lines. 
Specific Objectives  
 To determine the viability of HeLa cell lines treated with  G.umbrosus extracts  
 To determine morphology changes of the HeLa cell lines treated with G. 
umbrosus   
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Cancer 
Cancer is the worst public health problem in the United States and many other 
parts of the world. One in four deaths in the United States is due to cancer (Siegel et al., 
2014).  
Cancer is a disease that is defined as the uncontrollable cell proliferation that 
increases the number of abnormal cells. Cancer is a progressive disease which involved 
several stages, including the initiation caused by carcinogenic inducer, the initiation of 
development tumor cells, the progression into malignant cells and lastly by invasion and 
the metastasis of the cancer cells to other body parts (Metha et al., 2010). Cancer is a 
malignant disease caused by a fast and uncontrollable proliferation of abnormal cells 
that will also accumulate together to form a solid tumor and proliferate throughout the 
body which can cause death. Cancer cells are able to grow and invade the neighbouring 
tissue and may also metastasize to other organs through the lymphatic system or 
bloodstream (Knudson, 2001). 
According to a previous study in advanced cancer research in the last decade 
that was highlighted, there are at least 5 cancer-causing factors. These include are 
cytotoxic and/or inflammatory carcinogenic substances, spontaneous replication errors 
in DNA, genotoxic (direct DNA injurious) and chronic inflammatory. These factors are 
the key  point in promoting tumor proliferation and angiogenesis that causes  tumor 
growth (Coussens and Werb, 2002).  
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The National National Institute of Health, USA had estimated an overall of 
$209.9 billions were invested throughout the world in 2005 and had been a big 
challenge for the economical aspects.  
Cancer is usually treated by chemotherapy, surgery, immunotherapy, radiation 
therapy, monoclonal antibody therapy, or combinations of these methods. The treatment 
methods can be different depending on the type of cancer and location, disease stage, as 
well as the general health status of the patient (Coseri., 2009). 
Natural products represent one of the most valuable sources for new drugs 
development that still needs investigation of their specific function in medicinal field 
(Coseri, 2009). Many compounds originated from plants are frequently used in cancer 
therapy such as  vincristine, camptothecin, paclitaxel, and etoposide (Rocha et al., 
2001). These natural compounds have been chemically modified to make them more 
active, more safe, and more soluble (Srivastava et al., 2005). 
2.2  Cervical cancer 
The cervical cancer formation can be triggered via several factors such as 
genetic and environmental aspects. These include Human Papillomavirus (HPV) 
infection, sexual partners, smoking, age, HIV infection, family history of cervical 
cancer and long-term use of oral contraceptive (Schiffman and Brinton, 1995). 
The International Agency for Research on Cancer estimated 493,000 new cases 
and 274,000 deaths worldwide in the year 2003 (Bachtiary et al., 2006). The disease 
disproportion affects the poorest regions and more than 80% of causes found in Latin 
America, Sub-sahara Africa and India (Petignant and Roy, 2007). Recurrent of cervical 
cancer is almost always incurable and less than 5% of patients developed recurrence 
(Petignant and Roy, 2007). 
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2.3 HeLa cell lines 
HeLa (ATCC®CCL-2™) cell line is a cervix epithelial adenocarcinoma cell, an 
attached cell. The HeLa cells is the “immorrtal cell line” that is first successfully grown 
in a laboratory condition. A researcher from John Hopkins University, Otto obtained 
another cells sample from a black women patient, Henrietta Lacks who was undergoing 
treatment in that hospital (Spencer, 2009). T he sample cells was reported to contain 
HPV 18 strain, positive keratin by immunoperoxidase staining containing low level of 
p53 expression and normal level of pRB expression as referred from ATCC® 
(American Type Culture Collection) CCL-2™ product sheet.   
2.4  Medicinal plants  
Plants have developed complex mechanisms for their life such as space. Thus, 
some plants produce toxic substances, such as terpenes and alkaloids which will inhibit 
the growth of surrounding plants (Ramawat and Merillon., 2008). 
Plant-derived compounds over the years have been a very good source for 
medicinal use; many have been used as drugs, either in their original or semi-synthetic 
forms (Ramawat and Merillon., 2008) 
 High in effectiveness and safety have always been the gold standard for the 
discovery of new drug programs. The potential natural product from plants or others 
natural sources need to undergo screening to discover their pharmaceutical agents. Most 
of the time, the drug originated from natural sources show a significant segment of 
pharmaceutical market compared to randomly synthesized compounds ((Efferth and 
Koch., 2011) 
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 Therapeutic efficacy of phytotherapy is based on the combination action of a 
mixture of constituents, and since many diseases are multi-factorial in nature, it 
provides an effective treatment strategy (Efferth and Koch., 2011) 
In addition, the plant derived therapies usually have high effectiveness in their 
safety profiles. For example, the adverse reaction shown in chinese herbal medicine 
appears to relatively safe compared to prescription drug use (Shaw., 2012) 
Historically, plants with  known  therapeutic  potential  have been used for a 
long time  to  cure many diseases.  As an example, a morphine is a drug from a plant 
product that was discovered in 1861  as  an  analgesic  agent.  Later, the Cinchona bark 
that was isolated in 1820 has an active compound known as quinine and functions as an 
effective antimalarial drug (Rebecca., 2004; Gary and Bryn., 2003). 
The scientist continues to demonstrate many researches involving plants as the 
potential sources of treatment for complicated diseases. Nowadays, natural products for 
the treatment of Alzheimer's disease have attracted an interest among researchers (Park., 
2010) 
Plant derived compounds are also good in common health problems such as 
diabetes, hypertension and obesity. Recently, a number of randomized, controlled 
intervention trials have shown that drinking green tea catechins (270 mg to 1200 
mg/day) may reduce body weight and fat (Rain et al., 2011) 
There  are  some  plant-based natural  products  which  are commonly  used  in  
the treatment  of  hematological  malignancies  such  as  vinca  alkaloids,  which are 
used  to treat lymphomas  and  acute  lymphoblastic  leukemias (Karon  et  al.,  1966;  
Dancey and Steward., 1995),  and  podophyllotoxin  derivatives,  which is useful to treat 
acute myeloid leukemias, Hodgkin‟s  and non-Hodgkin‟s lymphomas (Hande,  1998).  
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Other than that, there are several plant-based natural products that have been 
under  clinical  trials  and shows  good potentials  to treat several haematological 
malignancies such as flavopiridol (Byrd et al.,  2007)  and meisoindigo (Wang  et  al.,  
2005;  Weng  et  al.,  2005).  Meanwhile, there are also the plant-based natural products 
that are still under preclinical studies for  haematological malignancies  treatment  such 
as  combretastatins and honokial  (Fang  et  al.,  2007;  Petit  et  al.,  2008; Battle et al., 
2005) 
2.5 Goniothalamus umbrosus 
2.5.1 Botanical description 
Goniothalamus species has uniform and simple characteristics, with few-leaved 
and the leaves are simple and alternate. The shrub is smooth and cylindrical. The blade 
is thick (Wiart., 2006). The flowers are easy to recognize by the calyx consists of three 
sepals which is commonly membranous or valvate shaped. The fruits are stalked or 
sessile one to two seeded ripe carpels (Saunders, 2003). The genus of Goniothalamus 
have been suggested to have been colonized in earth during the post-Permian early 
Cretaceous time (Wiart., 2007a) 
The synonym name for Goniothalamus umbrosus species is a Goniothalamus 
tapis Miq (Sinclair., 2003). 
2.5.2  Traditional Medicinal Uses 
G.umbrosus plants has been used for a long time ago in traditional medicinal 
Asian practices such as for abortion and and fever (Wiart., 2007b). The roots of the G. 
umbrosus was used as abortifacient during the early months of pregnancy (Burkill., 
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1953) and the typhoid fever was treated in Java, Indonesia by an infusion of the roots of 
G. umbrosus. 
 However, none of the medicinal properties of G. umbrosus has been 
substantiated yet via strict pharmacological experimentation but these species have been 
studied for their chemical compounds (Wiart., 2007a) 
2.5.3 Anticancer Studies 
The National Cancer Institute had collected about 35,000 plant samples from 20 
countries and around 114,000 extracts were screened for their anticancer property 
(Shoeb, 2005).   
 Twenty two species (13.7%) out of 160 species, in the genus Goniothalamus, 
have been phytochemically investigated including the G. umbrosus. These studies have 
resulted in two very distinct classes of lipophilic secondary metabolites: acetogenins 
and styryl-lactones, both possessing complex stereochemistry and existing in different 
stereoisomeric forms (Motoyuki et al., 2000).  
The research test for these chemical cytotoxity activity showed that styryl-
lactones and acetogenins are toxic for several human tumors cell lines (Yang and Yu., 
2000 ). These findings can be the evidence for the present anticancer, antibacterial and 
antiviral agents in the genus Goniothalamus and further consistent and systematic 
research on this genus will lead to the discovery of antineoplastic and antimicrobial 
agents (Wiart.,2007a). 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Plant materials 
 Plant material used in this study was Kenerak (Goniothalamus umbrosus) 
leaves. The plants materials were obtained from Machang, Kelantan.  
3.1.2 Cell line 
 Cell line used in this study were human cervix adenocarcinoma cell line (HeLa), 
HeLa cell line was obtained commercially (ATCC, USA or AllCells, USA). 
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3.1.3 Chemicals and reagents 
 Chemicals and reagents that were used in this study were listed in Table 3.1. 
Table 3.1: List of chemicals and reagents 
Name Source  
Trypan Blue Solution Sigma-Aldrich, USA 
Gibco® Dulbecco’s Modified Eagle Medium 
(DMEM) 
Invitrogen Inc, USA 
Gibco® Fetal Bovine Serum (FBS) Invitrogen Inc, USA 
Gibco® Penicilin-Streptomycin Invitrogen Inc, USA 
Gibco® Phosphate Buffered Saline Solution 
(PBS) 
Invitrogen Inc, USA 
Gibco® 0.25% Trypsin-EDTA Invitrogen Inc, USA 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, USA 
CellTiter 96® AQueous One Solution Cell 
Proliferation Assay 
Promega, USA 
alamarBlue® Cell Viability Assay Life technology, USA 
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 3.1.4 General commercials kits and consumables. 
Commercials kits and consumables that were used in this study were listed in 
Table 3.2. 
Table 3.2: List of commercials kits and consumables. 
Kits and consumables Sources  
Filter (0.2 µm) Milipore, Singapore 
6-well plates Nunc, Denmark 
Cell culture flask T25 cm
2
 and T75 cm
2
 Nunc, Denmark 
Cell culture tube Becton-Dickson, USA 
Centrifuge tubes, 15 ml and 50 ml Falcon Labware, USA 
Pipette tips Appendorf, USA 
50 ml syringe Becton-Dickson, USA 
Whatman no.1 filter paper Whatman Inc., New Jersey 
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3.1.5 Laboratory apparatus and equipment 
 Laboratory apparatus and equipment. used in this study were listed in Table 3.3. 
Table 3.3 : List of laboratory apparatus and equipments. 
Name Source  
Blender grinder Panasonic, Malaysia 
Centrifuge 5415R Eppendorf, Germany 
Class II Biohazard safety cabinet Esco Micro Pte. Ltd. Singapore 
CO2 Incubator Thermo Fischer Scientific, USA 
Freezer (-20ᵒC) Hitachi, Japan 
Freezer (-80ᵒC) Thermo Fischer Scientific, USA 
Phase contrast microscope Nikon Instrument Ins, USA 
Analytical balances 
Rotary evaporator 
Water bath for rotary evaporator 
Sartorious, Germany 
Eyela, N1100, USA 
Eyela, OSB2100,USA 
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3.2 Methods 
3.2.1 Collection and preparation of plant extracts 
 G. umbrosus leaves were obtained from Machang, Kelantan. The leaves were 
collected and washed thoroughly using distilled water in order to remove dust, soil and 
insects. The fresh leaves were then allowed to dry at room temperature (RT). The dried 
leaves were weighed and recorded before were grinded using a electrical blender. 
3.2.2  Extraction of plant extract 
The methanol aqueous extracts were performed by grinding the fresh leaves with 
methanol and distilled water in ratio of 4:1. The mixtures were incubated on the shaker 
for 3 days at 250 rpm, each one days the mixtures were filtered with 125 mm filter 
paper, after the filtration process the filtered extracts were stored in -4ᵒC, then the 
supernatants were be added with methanol and distilled water in ratio of 4:1, then the 
mixtures were incubated on shaker at 250 rpm for 24 hours. The process was continued 
for 3 times in 3 days. After the 3 times process of the filtration of the extracts, the 
filtered extracts were then pooled, concentrated and dry using freeze dryer for one 
week. The crude extracts were then stored at -20ᵒC until further use.  
3.2.3 Preparation of stock extracts 
 The 0.06 g crude extracts were dissolved in the 1000 µl sterile distilled water, 
Then, the extracts were sterilised using with 0.2 µm syringe filter and 50 µl of extracts 
was aliquoted and was dissolved in 3000 µl of medium at concentration of 1000 µg/ml . 
The excess filtered were kept in a falcon tube and stored at -20ᵒC.  
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3.2.4 Cell culture  
3.2.4.1 Cell lines  
HeLa cell lines was obtained commercially (ATCC, USA or AllCells, USA). 
The cells was cultured in Dulbecco‟s Modified Eagle‟s Medium (DMEM) containing 
10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin). The cultures was 
incubated at 37°C with 5% CO2 in 25 cm
2 
flask. The medium were replaced every 72 
hours and the cells was cultured until they reach 70% to 80% confluence. Only cell 
lines from passage 4 to passage 6 were used throughout the experiment. 
 
3.2.4.2 Thawing frozen cells 
 The frozen cells stored in the -80ᵒC were retrieved and rapidly thawed  by 
immersed in water  bath at 37ᵒC a few minutes. The cells suspension from cryotube then 
was transferred  into a 15 ml falcon tube and 3 ml pre-warmed medium added into the 
cell suspension. The mixtures then was centrifuged at 1000 rpm for 5 minutes. The 
supernatant was discarded and  1 ml of medium was added to pellet. The cell 
suspension was transferred to the culture flask with 4 ml of medium then incubated and 
maintained at 37ᵒC under humidified atmosphere, with 5% CO2 and 95% air. The 
medium were replaced every 72 hours and the cells was cultured until they reach 70% 
to 80% confluence. 
3.2.4.3 Preparation of cell suspension 
 For cell growth in monolayer culture, the 1 ml of 0.25% trypsin/EDTA was used 
to detach the cells from surface of culture flask and incubated for around 5-15 minutes 
in incubator at 37ᵒC. Then, 3 ml of complete medium was added to neutralise and stop 
the reaction of trypsin. To completely detach the cells the wall of flask was flushed for a 
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few times. The cell suspension in flask was collected by using 15 ml falcon tube and 
centrifuged at 1000 rpm for 5 minutes. The supernatant was discarded and cells were 
diluted in 1 ml complete medium and  resuspend its to obtain uniform suspension. 
Hundred  µl of DMSO was aliquoted, and  900 µl of the cell suspension was  resuspend  
in the 2 ml cryotube for storage and were slowly frozen from 4ᵒC to 20ᵒC before 
transferred to -80ᵒC freezer. Meanwhile, the cells suspended in 1 ml medium were ready 
to be cultured again in culture flask 
3.2.4.4 Subculturing cell lines 
 The cell cultures were propagated in large culture flasks until a confluent 
monolayer had formed. When the cells reached confluent 80% to 90%, the medium was 
removed  and rinse once with phosphate-buffer saline (PBS). The cell were detached 
from the cell culture flask using trypsin, collected in 5 ml falcon tube and centrifuged at 
1000 rpm for 5 minutes. After removing supernatant, the cell pellet was subsequently 
resuspended in 3 ml fresh complete medium. To subculture the cells in new flask, 500 
µl of the cell were aliquot into new cell culture flask containing fresh complete medium. 
The culture flask were shook gently to distribute the cell evently around the flask. The 
cell when incubated at 37ᵒC under humidified atmosphere, with 5% CO2 and 95% air. 
3.2.4.5 Cryopreservation of cells lines 
 Briefly, the confluent cells in the flask were trypsinised, collected, centrifuged, 
and supernatant was removed. After that, the cell pellet was suspended with 1 ml of 
fresh complete medium before aliquot 900 µl of the cell suspension and 100 µl of 
DMSO into labelled cryotube and sealed. To prevent cell undergo cool shock, the 
cryotube were secured with tissue paper, then were frozen in -80ᵒC freezer. 
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3.2.5 Determination of inhibitory concentration 50% (IC50) 
3.2.5.1 Leaf extracts preparation 
 G. umbrosus leaves extracts concentration were calculated based on the 
following formula (Ahmad et al., 2014): 
M1V1 = M2V2 
Where, 
M1 = initial concentration of G. umbrosus leaves extracts stock solution. 
V1 = initial volume of G. umbrosus leaves extracts stock solution. 
M2 = new concentration of G. umbrosus leaves after dilution. 
V2 = new volume of G. umbrosus leaves after dilution. 
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3.5.5.2 Treatment of HeLa cells with G. umbrosus leaves extracts 
 When the cells reaching confluent, the old medium was discarded and washed 
once with PBS, then 1 ml of trypsin was used to detach the cells, then incubated for 
around 5-15 minutes. Then, 3 ml of complete medium was added to neutralise and stop 
the reaction of trypsin. To completely detach the cells the wall of flask was flushed for a 
few times. The cell suspension in flask was collected by using 15 ml falcon tube and 
centrifuged at 1000 rpm for 5 minutes. The supernatant was discarded and cells were 
diluted in 1 ml complete medium and resuspend its to obtain uniform suspension.  
Total number of 5 x 10
3
 cell was pipette into each of the well with 100 µl of 
fresh medium in each well of 96-well plate,. After 24 hours, old medium was discarded 
and replaced with mixture of 100 µl of fresh complete medium with G. umbrosus with 
varying range. The untreated cells or control cells were exposed with complete medium 
without G. umbrosus leaves extracts. The cultures was incubated at 37°C with 5% CO2. 
After 72 hours of incubation times, then cells were undergo MTS and AlamarBlue assay 
method for determined the viability of cells. 
 Graphs of cell viability against G. umbrosus leaves extracts concentration 
plotted and the percentage of inhibitation of cells were compared with the untreated 
cells group. The IC50 of the extracts was determined as concentration of extracts that 
killed 50% of the viable cells. 
3.2.5.3 Cell count using trypan blue 
 Cell count was carried out according to the manufacturer protocol, with slight 
modification on the volume and dilution factor. Briefly, from 1 ml cell suspension, 50 
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µl of cells were aliquot into 1.5 ml eppendorf tube and mixed with 50 µl of  trypan blue 
dye in 1:1 ratio. The mixtures were mixed well by resuspend using a pippete. After 
incubation of 1 minute, 10 µl of cell suspension diluted in trypan blue solutions was 
transferred into the cell counter slide and was read by a cell counter machine. 
3.2.6 Microscopic observation of morphological changes 
 The human cervix adenocarcinoma cell lines, HeLa cells were seeded at 5 x 10
4
 
cells in a 6-well plate. After 24 hours growth, the old medium from 6-well plates was 
removed and replace with the varied concentration of the mixtures from fresh medium 
and extracts. Then, the cell cultures  treated with extracts was incubated for 72 hours at 
37ᵒC with 5% CO2 humidified atmosphere. For the control untreated cells, the cell 
culture was exposed to medium without any extracts. Morphological changes of the 
cells were observed under phase contrast microscope. Morphology changes of the cell 
were observed according to varying of concentration applied. The features related to 
apoptosis or cell death mechanism were identified on the HeLa cells treated with 
extracts. The pictures of cell cultures were captured in 40x and 100x magnification with 
Olympus Xcam_Alpha camera attached to the phase contrast microscope. 
3.2.7 Cell proliferation assay  
3.2.7.1 Cell proliferation assay using MTS assay method 
Cell proliferation assay was done with total number of 5 x 10
3
 cell was pipette 
into each of the well with 100 µl of fresh medium in each well of 96-well plate. After 24 
hours, old medium was discarded and replaced with mixture of 100 µl of fresh complete 
medium with G. umbrosus with varying range. The untreated cells or control cells were 
exposed with complete medium without G. umbrosus leaves extracts. The cultures was 
incubated at 37°C with 5% CO2. After 72 hours of incubation period, cells were treated 
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with varying concentration of G. umbrosus leaves extracts in triplicates, then 20 µl of 
AlamarBlue assay were added in each of 100 µl of mixture of fresh complete medium 
with extracts in varying concentration. Then the mixture were incubated between 2 to 4 
hours before the absorbanced were calculated using 96-well ELISA reader at 460 nm of 
wavelength. 
3.2.7.2 Cell proliferation assay using AlamarBlue assay method 
 Cell proliferation assay was done with total number of 5 x 10
3
 cell was pipette 
into each of the well with 100 µl of fresh medium in each well of 96-well plate,. After 
24 hours, old medium was discarded and replaced with mixture of 100 µl of fresh 
complete medium with G. umbrosus with varying range. The untreated cells or control 
cells were exposed with complete medium without G. umbrosus leaves extracts. The 
cultures was incubated at 37°C with 5% CO2. After 72 hours of incubation times, cells 
were treated with varying concentration of G. umbrosus leaves extracts in triplicates, 
then 20 µl of AlamarBlue assay were added in each of 100 µl of mixture of fresh 
complete medium with extracts in varying concentration. Then the mixture were 
incubated between 2 to 4 hours before the absorbanced were calculated using 96-well 
ELISA reader at 460 nm of wavelength. 
 
 
 
 
 
21 
 
CHAPTER 4 
RESULTS 
This study was carried out to determine the potential of G. umbrosus as 
promising chemopreventation agents against cervical cancer cells. The G. umbrosus 
leaves extracts were tested on cervical cell cancer cells (HeLa cells).  
4.1 Extraction Yield 
 The mass of G. umbrosus leaves before and after aqueous 80% methanol 
extraction was shown in Table 5.1. The yield of aqueous 80% methanol extraction of G. 
umbrosus leaves showed 4.45% yield of extraction.  
Table 4.1 : Mass of G. umbrosus leaves 
Items  Leaves (g) Methanol : water (ml) 
(4:1) 
 
Before extraction 
(fresh leaves) 
 
88.22 400 : 100 
 
 
After extraction  
(concentrated  
& powdered) 
 
3.93 - 
% yield extraction 4.45 - 
 
 
 
 
 
 
 
22 
 
4.2 Cellullar growth inhibition of G. umbrosus and the determination of 
inhibitory concentration 50% (IC50) on HeLa cells.  
 The evaluation of G. umbrosus leaves extracts in inhibiting the cells growth and 
cell proliferation on HeLa cells upon treatment for 72 hours were conducted. Therefore, 
G. umbrosus leaves extracts were screened with different concentration ranges and the 
inhibitory concentration 50% (IC50) for extracts were determined against untreated 
HeLa cells using AlamarBlue and MTS method.  
Table 4.2 (a) and table  4.2 (b) showed HeLa cells concentration and cell 
viability after treated with G. umbrosus leaves extracts by using AlamarBlue and MTS 
method respectively. In addition, Figure 4.1 (a) and Figure 4.1 (b) showed the 
G.umbrosus leaves have reduced the HeLa cells growth as compared to untreated cells 
in a dose-dependent manner respectively which were analyses by AlamarBlue and 
MTS. Whereas Figure 4.2 (a) and Figure 4.2 (b) showed the percentage of viable cell 
upon treatment with G. umbrosus leaves extracts using the AlamarBlue and MTS. The 
concentration of G.umbrosus leaves extracts ranges from 31.25 µg/ml, 62.5 µg/ml, 125 
µg/ml, 250 µg/ml, 500 µg/ml, and 1000 µg/ml. The IC50 value was determined as in 
between range of 31.25 µg/ml and 62.5 µg/ml respectively. The experiment was 
conducted in triplicate.  
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Table 4.2 (a) : HeLa cell concentration and cell viability treated with G. umbrosus 
leaves extracts analyses by using AlamarBlue. 
Concentration  of leaves 
extract (µg/ml) 
Cell concentration  
(5 x10
3 
cells/well) 
Cell viability (%) 
 
 
Ctrl  0.23 100 
31.25 0.16 57.14 
62.5 0.13 46.43 
125 0.103 36.79 
250 0.09 32.14 
500 0.05 17.86 
1000 0.03 10.71 
 
 
Table 4.2 (b) : HeLa cell concentration and cell viability treated with G. umbrosus 
leaves extracts analyses by using MTS. 
Concentration of leaves 
extract  (µg/ml) 
Cell concentration  
(5 x10
3 
cells/well) 
Cell viability (%) 
 
 
Ctrl  1.162 100 
31.25 0.696 59.87 
62.5 0.526 45.27 
125 0.279 24.01 
250 0.236 20.31 
500 0.161 13.86 
1000 0.127 10.93 
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(a) 
 
(b)  
 
 
Figure 4.1 : Cell growth of HeLa cells treated with G. umbrosus leaves extracts (a) 
Analyses by AlamarBlue (b) Analyses by MTS. Values were presented in manner of the 
triplicates.  
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